# Heading: Efficacy of Lactic Acid Bacteria Isolated from Winemaking Byproducts in Preventing Alcoholic Liver Injury

**Authors:** Min-Wei Hsieh, Huey-Yueh Chen, Cheng-Chih Tsai

PMC · DOI: 10.1007/s12088-025-01506-8 · Indian Journal of Microbiology · 2025-07-16

## TL;DR

This study explores how lactic acid bacteria from winemaking byproducts can help prevent liver damage caused by alcohol.

## Contribution

The study identifies specific lactic acid bacteria strains from winemaking byproducts that effectively reduce alcoholic liver injury.

## Key findings

- Strains tau 2–8 and tau 1–1 maintained viability in high alcohol concentrations.
- Strains 3–14 and 6–10 reduced AST levels in HepG2 cells by up to 107%.
- Lactic acid bacteria feeding significantly improved liver enzyme levels and reduced fatty liver in animal models.

## Abstract

The primary cause of liver damage due to alcohol consumption is long-term intake that disrupts normal metabolism. We focused on evaluating the screening of lactic acid bacteria (LAB) derived from winemaking byproducts to prevent alcoholic liver damage. We employed in vitro cell tests to determine the effect of probiotics on reducing cytokine levels (INF-γ, TNF-α, IL-6, IL-8) and alcohol content after LPS-induced inflammation of alcoholic liver cells. We also analyzed the levels of aspartate transaminase (AST) and alanine transaminase (ALT) after hepatocyte injury. The results showed that strain tau 2–8 (107) and strain tau 1–1 (107) could maintain a viable count above 6 Log CFU/mL at 20% alcohol concentration. Moreover, strain 3–14 (106) and strain 6–10 (107) effectively reduced AST content in HepG2 cells stimulated by alcohol, with clearance rates of 107 and 105%, respectively. In the animal experiments, feeding single and combination multi-strains at the eighth week resulted in AST levels decrease significantly compared to the alcohol group in serum. Specifically, the single strain 3–14 (106) and the combined multi-strain had better effects, reducing AST levels by 54 and 48%, respectively. Additionally, the serum triglyceride content of the group under an alcoholic diet increased over time, but feeding with lactic acid bacteria resulted in a significant decrease. The glutathione peroxidase enzyme activity of the alcohol group decreased by 31.9% compared to the control group, while feeding with single-strain lactobacillus and combined lactobacillus groups increased significantly. Feeding lactic acid bacteria effectively reduced and improved alcoholic fatty liver and liver damage. In this study, LAB derived from the utilization of winemaking by-products also helps to manage wine industrial waste in an efficient way.

## Linked entities

- **Proteins:** INFG (interferon gamma), TNF (tumor necrosis factor), IL6 (interleukin 6), CXCL8 (C-X-C motif chemokine ligand 8), GOT1 (glutamic-oxaloacetic transaminase 1), GPT (glutamic--pyruvic transaminase), GPX2 (glutathione peroxidase 2)
- **Chemicals:** alcohol (PubChem CID 702), triglyceride (PubChem CID 5460048)
- **Diseases:** alcoholic fatty liver (MONDO:0021104)

## Full-text entities

- **Genes:** CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Hgf (hepatocyte growth factor) [NCBI Gene 15234] {aka C230052L06Rik, HGF/SF, NK1, NK2, SF, SF/HGF}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, Il1 (interleukin 1 complex) [NCBI Gene 111343] {aka Il-1}, Sod1 (superoxide dismutase 1) [NCBI Gene 24786] {aka CuZnSOD}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, ATHS (atherosclerosis susceptibility (lipoprotein associated)) [NCBI Gene 470] {aka ALP}, Prdx6-ps2 (peroxiredoxin 6 pseudogene 2) [NCBI Gene 384001] {aka Aop2-rs2, GPx*, Prdx6-rs2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, GSR (glutathione-disulfide reductase) [NCBI Gene 2936] {aka CNSHA10, GR, GSRD, HEL-75, HEL-S-122m}, Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, Gpx1 (glutathione peroxidase 1) [NCBI Gene 24404] {aka GSHPx, GSHPx-1}, CAT (catalase) [NCBI Gene 847], Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}
- **Diseases:** Alcoholic Liver Injury (MESH:D008108), hepatic fat (MESH:D005218), Fatty liver disease (MESH:D005234), inflammatory cytokines (MESH:D000080424), Alcoholic fatty liver (MESH:D005235), hepatic damage (MESH:D056486), Liver injury (MESH:D017093), liver cancer (MESH:D006528), colon adenocarcinoma (MESH:D003110), Chronic liver disease (MESH:D008107), Inflammatory (MESH:D007249), Hepatocyte injury (MESH:D014947), cirrhosis (MESH:D005355), alcohol abuse (MESH:D000437), non-alcoholic fatty liver (MESH:D065626), alcoholic hepatitis (MESH:D006519), toxicity (MESH:D064420), liver fibrosis (MESH:D008103), weight loss (MESH:D015431)
- **Chemicals:** water (MESH:D014867), unsaturated fats (MESH:D005224), GSH (MESH:D005978), CO2 (MESH:D002245), L-cysteine (MESH:D003545), lipid (MESH:D008055), LPS (MESH:D008070), vitamin A (MESH:D014801), eosin (MESH:D004801), Alcohol (MESH:D000438), Cholesterol (MESH:D002784), formalin (MESH:D005557), ethanol (MESH:D000431), ROS (MESH:D017382), paraffin (MESH:D010232), DMEM (-), silymarin (MESH:D012838), fat (MESH:D005223), sodium bicarbonate (MESH:D017693), Bile salts (MESH:D001647), H&amp;E (MESH:D006371), phosphate (MESH:D010710), maltodextrin (MESH:C008315), acid (MESH:D000143), hematoxylin (MESH:D006416), glycerol (MESH:D005990), alpha-lipoic acid (MESH:D008063), lactic acid (MESH:D019344), vitamin E (MESH:D014810), TG (MESH:D014280), GSSG (MESH:D019803), selenium (MESH:D012643), carbohydrates (MESH:D002241), oil (MESH:D009821), lipid peroxides (MESH:D008054)
- **Species:** Limosilactobacillus fermentum (species) [taxon 1613], Lacticaseibacillus paracasei (species) [taxon 1597], Limosilactobacillus reuteri (species) [taxon 1598], Nicotiana tabacum (American tobacco, species) [taxon 4097], Lactobacillus acidophilus (species) [taxon 1579], Pediococcus pentosaceus (species) [taxon 1255], Lactiplantibacillus plantarum (species) [taxon 1590], Leptospira sp. AB (species) [taxon 103236], Rattus norvegicus (brown rat, species) [taxon 10116], Lactobacillus johnsonii (species) [taxon 33959], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Ligilactobacillus salivarius (species) [taxon 1624], Mus musculus (house mouse, species) [taxon 10090], Lacticaseibacillus rhamnosus GG (strain) [taxon 568703], Homo sapiens (human, species) [taxon 9606], Lactobacillus (genus) [taxon 1578]
- **Cell lines:** C57BL/6N — Mus musculus (Mouse), Embryonic stem cell (CVCL_2H81), C2BBel — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0529), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), Hep G2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), /6N — Mus musculus (Mouse), Transformed cell line (CVCL_D461)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12909721/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12909721/full.md

---
Source: https://tomesphere.com/paper/PMC12909721